A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis

PETERS, D., L. NORRIS, L. TENORA, I. SNAJDR, A. PONTI, X. ZHU, S. SAKAMOTO, V. VEERVALLI, M. PRADHAN, J. ALT, A. THOMAS, P. MAJER, R. RAIS, C. MCDONALD, B. SLUSHER
A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis. Science Translational Medicine. 2023, 15(708), eabn7491, ISSN: 1946-6234, PMID: 37556558,